“Global Insight Services company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
The injection pen market was valued at USD 37.8 billion in 2023 and it is anticipated to grow further to USD 75.7 billion by 2033, at a CAGR of 7.2% during the forecast period.
View The Full Report Here –https://www.globalinsightservices.com/reports/injection-pen-market/?utm_id=Pranalip
The medication is injected into the body using injection pens. They are employed to administer insulin to the patient. Patients can adhere to the prescribed treatment plan with the aid of injectable pens. This method has assisted in enhancing the patient’s quality of life and lowering healthcare costs. The injection pen approach is a self-management treatment option for multiple sclerosis and diabetes that is widely used by top pharmaceutical businesses as a drug delivery system. An injection pen has an insulin cartridge, a disposable pen, a needle, and a dial for dosage measurement.
Market Trends and Drivers
In recent years, there has been a dramatic rise in the prevalence of chronic illnesses. Multiple sclerosis, diabetes, osteoporosis, cardiovascular disease (CVD), and other illnesses call for the administration of injectable medications on a daily or weekly basis. Due to the frequent drug administration, injector pens are the best choice for chronic disorders. Injection pens have become the new standard for injectable medicine delivery methods. Their ease of use, dependability, and capacity to be provided by the patient alone without the assistance of a doctor have caused their popularity to grow. In order to effectively manage the expanding patient population and improve patient compliance with therapies, injectable pen technologies have come under more scrutiny as a result of the rising prevalence of chronic diseases.
Market Restraints and Challenges
Devices for injecting are not the only options available. The primary deterrents for using injectable pens are fear of needle sticks and harm. Therefore, there are many needle-free devices that have the extra benefit of not causing needle fear, which is a major barrier to the increased use of injectable medication therapies. Children’s and adults’ non-complacency is mostly related to the discomfort of the daily injections and the demands of long-term therapy. Additionally, because the dose cannot be controlled, insulin pen therapy is seen to result in hyperglycemia in certain patients. Due to their capability to execute automated insulin suspension and reduce the danger of hypoglycemia, insulin pumps have therefore replaced insulin pens in the treatment of diabetes in Europe.
Request A Sample Of This Report –https://www.globalinsightservices.com/request-sample/GIS10308/?utm_id=Pranalip
Major Players in the Global Injection Pen Market
The major players studied in the market are Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Ypsomed Holding AG (Switzerland), Sanofi (France), Eli Lilly and Company (US), Merck KGaA (Germany), AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Owen Mumford (UK), Sulzer Ltd. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Pfizer (US), Biocon Ltd. (India), Lupin Ltd. (India), and Wockhardt Ltd. (India) among others.
COVID-19 Impact
In individuals with COVID-19, diabetes has been directly linked to disease severity and mortality. This fact is supported by the rising morbidity and mortality rates that have been associated with inflammation, hypercoagulation, and weakened immune systems. Both hypoglycemia and hyperglycemia are indicators of worse outcomes in individuals who are hospitalized. To lessen the risk of severe COVID-19, individuals with diabetes and SARS-CoV-2 infection should strive for optimal glycemic management. With regard to treating asymptomatic and non-critically ill COVID-19 diabetic patients, both insulin and GLP-1RAs have demonstrated excellent glucose-lowering and anti-inflammatory benefits in type 2 diabetes patients. In order to change the dosage of insulin or anti-diabetic medications and conduct strict glucose monitoring, customized therapies for diabetes management are now required. For accurate tracking and ideal diabetes control, more people are using insulin pens, insulin pumps, and continuous glucose monitors. Diabetes management makes extensive use of injection pens. Therefore, any change in the total demand for products and services would inevitably have an effect on these.
Customise This Report As Per Your Requirements –https://www.globalinsightservices.com/request-customization/GIS10308/?utm_id=Pranalip
The COVID-19 pandemic had no effect on the market for injectable pens. Patients who were already utilizing injectable pens for a variety of medicines kept doing so throughout the pandemic. However, mobility limitations, closed borders, and a drop in overall trade damaged the supply chain for injection pens. Patients with COVID-19 infection who underwent therapy have a greater risk of developing diabetes. Therefore, if the prevalence of diabetes rises, so will the demand for injectable pens.
Market Segmentation
TYPE – Disposable Pens, Reusable Pens, THERAPEUTIC AREA – Diabetes Care, Anaphylaxis, Growth Hormone Therapy, Fertility Treatment, Osteoporosis Treatment, Other Therapeutic Areas, DISTRIBUTION CHANNEL – Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, NEEDLE TYPE – Standard Pens, Safety Pens, USAGE – Manual Injection Pens, Autoinjector Pens, END USER – Hospitals, Clinics, Homecare Settings
Buy Now-https://www.globalinsightservices.com/checkout/single_user/GIS10308/?utm_id=Pranalip
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.